Sintomi psichiatrici e disturbi comportamentali nelle demenze

Quali interventi?

Translated title of the contribution: How to treat psychiatric symptoms and behavioral disorders in dementia?

E. Riva, A. Nobili

Research output: Contribution to journalArticle

Abstract

It is estimated that about one-half of patients with dementia develops psychotic and/or behavioural signs and symptoms which cause distress and difficulties to families and healthcare professionals. The prevalence and the type of problem behaviours vary remarkably with neuropathology, course of the disease, severity of cognitive impairment, comorbidity and concomitant pharmacological therapies. It also varies in relation to the study setting, sample size and rating instruments for assessment. Careful history taking and clinical examination are the basis for sound treatment of these patients. Good quality nursing care is paramount and non pharmacological interventions may be of help in many cases. Neuroleptics are the only documented pharmacological treatment for psychosis in dementia and are best documented for agitation; they are also useful for the treatment of suspicion, delusions and hallucinations. There is no evidence of a difference in efficacy among various antipsychotic agents. Benzodiazepines can be helpful in the management of anxiety and sleep disturbances. Antidepressants can improve the patient's mood, functional state and quality of life. All these compounds have a number of potentially severe adverse effects that caution against their widespread use in patients with dementia, which are mostly elderly, and at high risk of developing untoward reactions.

Original languageItalian
Pages (from-to)81-91
Number of pages11
JournalRicerca e Pratica
Volume15
Issue number86
Publication statusPublished - 1999

Fingerprint

Behavioral Symptoms
Psychiatry
Dementia
Pharmacology
Antipsychotic Agents
Delusions
Quality of Health Care
Hallucinations
Therapeutics
Nursing Care
Benzodiazepines
Psychotic Disorders
Sample Size
Antidepressive Agents
Signs and Symptoms
Comorbidity
Sleep
Anxiety
Quality of Life
Delivery of Health Care

ASJC Scopus subject areas

  • Pharmacology

Cite this

Sintomi psichiatrici e disturbi comportamentali nelle demenze : Quali interventi? / Riva, E.; Nobili, A.

In: Ricerca e Pratica, Vol. 15, No. 86, 1999, p. 81-91.

Research output: Contribution to journalArticle

@article{958867efe67146ef881b5100625aee40,
title = "Sintomi psichiatrici e disturbi comportamentali nelle demenze: Quali interventi?",
abstract = "It is estimated that about one-half of patients with dementia develops psychotic and/or behavioural signs and symptoms which cause distress and difficulties to families and healthcare professionals. The prevalence and the type of problem behaviours vary remarkably with neuropathology, course of the disease, severity of cognitive impairment, comorbidity and concomitant pharmacological therapies. It also varies in relation to the study setting, sample size and rating instruments for assessment. Careful history taking and clinical examination are the basis for sound treatment of these patients. Good quality nursing care is paramount and non pharmacological interventions may be of help in many cases. Neuroleptics are the only documented pharmacological treatment for psychosis in dementia and are best documented for agitation; they are also useful for the treatment of suspicion, delusions and hallucinations. There is no evidence of a difference in efficacy among various antipsychotic agents. Benzodiazepines can be helpful in the management of anxiety and sleep disturbances. Antidepressants can improve the patient's mood, functional state and quality of life. All these compounds have a number of potentially severe adverse effects that caution against their widespread use in patients with dementia, which are mostly elderly, and at high risk of developing untoward reactions.",
author = "E. Riva and A. Nobili",
year = "1999",
language = "Italian",
volume = "15",
pages = "81--91",
journal = "Ricerca e Pratica",
issn = "1120-379X",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "86",

}

TY - JOUR

T1 - Sintomi psichiatrici e disturbi comportamentali nelle demenze

T2 - Quali interventi?

AU - Riva, E.

AU - Nobili, A.

PY - 1999

Y1 - 1999

N2 - It is estimated that about one-half of patients with dementia develops psychotic and/or behavioural signs and symptoms which cause distress and difficulties to families and healthcare professionals. The prevalence and the type of problem behaviours vary remarkably with neuropathology, course of the disease, severity of cognitive impairment, comorbidity and concomitant pharmacological therapies. It also varies in relation to the study setting, sample size and rating instruments for assessment. Careful history taking and clinical examination are the basis for sound treatment of these patients. Good quality nursing care is paramount and non pharmacological interventions may be of help in many cases. Neuroleptics are the only documented pharmacological treatment for psychosis in dementia and are best documented for agitation; they are also useful for the treatment of suspicion, delusions and hallucinations. There is no evidence of a difference in efficacy among various antipsychotic agents. Benzodiazepines can be helpful in the management of anxiety and sleep disturbances. Antidepressants can improve the patient's mood, functional state and quality of life. All these compounds have a number of potentially severe adverse effects that caution against their widespread use in patients with dementia, which are mostly elderly, and at high risk of developing untoward reactions.

AB - It is estimated that about one-half of patients with dementia develops psychotic and/or behavioural signs and symptoms which cause distress and difficulties to families and healthcare professionals. The prevalence and the type of problem behaviours vary remarkably with neuropathology, course of the disease, severity of cognitive impairment, comorbidity and concomitant pharmacological therapies. It also varies in relation to the study setting, sample size and rating instruments for assessment. Careful history taking and clinical examination are the basis for sound treatment of these patients. Good quality nursing care is paramount and non pharmacological interventions may be of help in many cases. Neuroleptics are the only documented pharmacological treatment for psychosis in dementia and are best documented for agitation; they are also useful for the treatment of suspicion, delusions and hallucinations. There is no evidence of a difference in efficacy among various antipsychotic agents. Benzodiazepines can be helpful in the management of anxiety and sleep disturbances. Antidepressants can improve the patient's mood, functional state and quality of life. All these compounds have a number of potentially severe adverse effects that caution against their widespread use in patients with dementia, which are mostly elderly, and at high risk of developing untoward reactions.

UR - http://www.scopus.com/inward/record.url?scp=0033033362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033033362&partnerID=8YFLogxK

M3 - Articolo

VL - 15

SP - 81

EP - 91

JO - Ricerca e Pratica

JF - Ricerca e Pratica

SN - 1120-379X

IS - 86

ER -